Neurogenic tumor: Teaching Points
Case Report
39 yr male with biopsy from swelling in
posterior aspect of left knee suggesting neurogenic tumor presents for MRI left
knee with contrast which shows –
Moderate size (25 mm approx.) regular intense
homogeneously enhancing rounded SOL posterior to knee joint in soft tissue
separate from popliteal vessels ( indenting them) with –
-
T1 hypointense / T2
heterogeneous hyperintense / few dots of possible vessels in GRE.
-
Split fat sign positive.
-
Fascicular sign positive.
-
Target sign negative.
-
No denervation of muscles in
vicinity.
-
No perilesional edema like
zone.
-
No intratumoral cyst
formation.
-
No fluid levels.
-Consistent with history suggesting
peripheral nerve sheath tumor like schwannoma with no definite MR features of
malignant transformation.
A well defined subcortical, complex, subtly
& heterogeneously enhancing posterior metadiaphyseal femoral lesion & an ill defined subchondral similar enhancing
posterolateral tibial condylar lesion with no cortical breach / expansion /
soft tissue involvement / bleed / intra articular extension - not specific to etiology, however may
represent nonossifying fibroma of femur & nonspecific subchondral tibial
lesion. DDs- hemangioma/ infarctions / unusual intraosseous neurogenic
components.
Case Submitted by Dr MGK Murthy & Dr GA Prasad
Discussion –
Peripheral nerve
sheath tumors consist of neurofibromas and schwannomas in the benign category &
malignant peripheral nerve sheath tumor (MPNST) in malignant category.
Imaging features
and signs that help to identify and characterize a nerve sheath tumor are,
distribution of the tumor along a major nerve, an entering or exiting nerve
sign, target sign, a fascicular sign and a split-fat sign.
-
Distribution of the lesion along the course of
the nerve is most
important feature. Benign lesions may be located along the cutaneous or deep
nerves, however, their malignant counterparts are seen most commonly along the
major nerve trunk. Neurofibromas are seen most commonly in the head and neck
regions, while schwannomas are more common in the lower extremity. The dumbbell
shape is characteristically seen in paraspinal neurofibromas, in which
intraspinal extension of the tumor causes widening of the neural canal.
-
Entering or exiting nerve sign - Neurofibromas are
characterized by fusiform enlargement of the nerve, with the tapered ends of
the lesion toward the parent nerve. Schwannomas are usually located
eccentrically in relation to the nerve. The plexiform variant of the
neurofibroma causes a diffuse expansion and enlargement of the parent nerve
resulting in a ‘bag of worms’ appearance on imaging as well as on gross
pathological examination.
-
Target sign – in T2W
images as a central area of hypointensity with a peripheral hyperintensity,most
often seen with neurofibromas with postcontrast study showing central enhancement with hypointense rim due
to central fibrocollagenous core and a surrounding myxomatous tissue. However,
the target sign may be seen in schwannomas
due to central distribution of the more cellular Antoni type A cells,
with a surrounding rim of hypocellular Antoni type B cells. The presence of
this sign in a malignant peripheral nerve sheath tumor is indicative of benign
tissue within the lesion, however, the absence of this sign in a lesion is
indicative of a malignant transformation of the primary benign lesion.
-
Fascicular sign – seen as multiple ring-like structures, which appear as
hypointense foci within the hyperintense area on T2W images, possibly
reflecting the fascicular bundles seen histologically and is often seen in
benign nerve sheath tumors and can occasionally be seen in tumors with focal
malignant transformation.
-
Split fat sign – presence of fat at the upper and
lower poles of a lesion on T1W images suggestive of the intermuscular location
of the lesion, although it is not specific to neurogenic tumors, can be seen in
other soft tissue tumors arising in the intermuscular location. It is a feature
of benignity, as malignant lesions tend to be more infiltrative in nature,
resulting in the obliteration of fat at the ends of the lesion.
-
Muscular atrophy - The
presence of a lesion with associated regional muscular atrophy in the neural
distribution is indicative of a nerve sheath tumor. On imaging, it is best seen
on T1W images as hyperintense areas, secondary to fatty replacement,
interspersed within normal-appearing muscles.
-
T2 hyperintense rim - seen
commonly in cases of schwannomas, as compared to neurofibromas.
-
Intra-tumoral cysts - more
common feature of schwannomas, as compared to neurofibromas.
Signs of malignant peripheral nerve sheath tumors -
-
Benign lesions are usually
smaller than 5 cm, and an increase in size of these lesions is highly
suggestive of a malignant transformation that requires histopathological
confirmation.
-
Malignant lesions tend to be more
heterogeneous on T1W and T2W images due to the necrotic and hemorrhagic areas
within, however, a similar heterogeneity can be seen in cases of long-standing
cases of schwannomas that have undergone degeneration.
-
Perilesional edema seen as an
area of increased signal intensity on T2W images, adjacent to the primary
lesion, suggestive of perilesional infiltration or edema.
-
Malignant tumors may show solid
or peripheral enhancement, which differentiates them from neurofibromas that
show focal central enhancement (Target sign), however, enhancement patterns
similar to malignant peripheral nerve tumors can be seen in schwannomas, due to
the areas of degeneration in them.
-
Bony involvement in the form of
destruction favors malignant lesion.
-
FDG PET/CT can possibly
differentiation between benign and malignant lesions based on the difference in
the fluorodeoxygenase (FDG) uptake by the benign and malignant lesions with
malignant lesions showing significantly higher specific uptake values (SUVs) as
compared to the neurofibromas. The SUVs
in cases of schwannomas are higher as compared to the neurofibromas and may
sometimes have an overlapping pattern, as in malignant peripheral nerve sheath
tumor.
Neurogenic tumor: Teaching Points
Reviewed by Sumer Sethi
on
Monday, February 18, 2019
Rating:
No comments:
Post a Comment